PDS Biotech to Present at HC Wainwright 26th Annual Global Investment Conference Page 1

PRINCETON, N.J., Sept. 3, 2024 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming the way the immune system attacks and kills cancer and developing vaccines against infectious diseases, today announced that Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS Biotech, will present at the HC Wainwright 26th Annual Global Investment Conference taking place September 9-11, 2024 in New York City.

Details of the presentation are as follows: